Sihuan Pharmaceutical Holdings Group (TEL1) Financial Statements
Sihuan Pharmaceutical Holdings Group Financial Overview
Sihuan Pharmaceutical Holdings Group's market cap is currently $769.38M. The company's EPS TTM is $0.03; its P/E ratio is 18.42; and it has a dividend yield of 1.25%. Sihuan Pharmaceutical Holdings Group has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.62B | $ 1.90B | $ 1.86B | $ 2.18B | $ 3.04B |
| Gross Profit | $ 1.80B | $ 1.24B | $ 1.30B | $ 1.49B | $ 2.43B |
| Operating Income | $ 607.12M | $ -138.13M | $ 161.70M | $ -1.83B | $ 771.95M |
| EBITDA | $ 702.00M | $ -130.98M | $ 334.31M | $ -1.54B | $ 985.56M |
| Net Income | $ 179.70M | $ -216.66M | $ -54.02M | $ -1.91B | $ 416.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.98B | $ 3.63B | $ 4.48B | $ 4.79B | $ 5.79B |
| Total Assets | $ 11.64B | $ 10.53B | $ 11.54B | $ 12.14B | $ 14.50B |
| Total Debt | $ 1.01B | $ 942.76M | $ 1.26B | $ 1.29B | $ 1.08B |
| Net Debt | $ -2.55B | $ -2.58B | $ -2.63B | $ -2.54B | $ -4.60B |
| Total Liabilities | $ 4.73B | $ 5.58B | $ 6.40B | $ 6.50B | $ 5.35B |
| Stockholders' Equity | $ 5.85B | $ 4.37B | $ 4.43B | $ 4.74B | $ 8.28B |
| Cash Flow | |||||
| Free Cash Flow | $ -218.06M | $ 57.51M | $ -95.93M | $ -355.97M | $ 64.28M |
| Operating Cash Flow | $ -23.56M | $ 243.89M | $ 199.49M | $ 46.49M | $ 665.29M |
| Investing Cash Flow | $ -296.48M | $ 758.24M | $ 169.88M | $ -1.66B | $ -337.57M |
| Financing Cash Flow | $ 358.16M | $ -1.26B | $ -419.56M | $ -238.93M | $ 750.66M |
Currency in CNY